Primary Category:
Radiation Oncology, Treatment Protocols
Disease Category:
Head and Neck
Status:
Open
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
NCT#01810913
